Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock
MENLO PARK, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it intends to offer and sell $85.0 million of shares of its common stock and a selling stockholder intends to offer 1,304,348 of common stock shares in an underwritten public offering. Pacific Biosciences also intends to... Read more
Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock
MENLO PARK, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it intends to offer and sell $85.0 million of shares of its common stock and a selling stockholder intends to offer 1,304,348 of common stock shares in an underwritten public offering. Pacific Biosciences also intends to... Read more
MTS Awarded Contracts Valued At $2.5 Million For New Electric Systems
EDEN PRAIRIE, Minn., Nov. 10, 2020 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of advanced test systems, motion simulators and precision sensors, today announced new awards for two electrically actuated systems totaling $2.5 million in contractual value. MTS will utilize electric technologies to design an improved helicopter pilot training system, featuring more... Read more
Brooks Automation Reports its Fourth Quarter and Year-End Results of Fiscal 2020, Ended September 30, 2020, and Announces Quarterly Cash Dividend
Brooks Automation Reports its Fourth Quarter and Year-End Results of Fiscal 2020, Ended September 30, 2020, and Announces Quarterly Cash Dividend Significant Earnings Growth Driven by Operating Margin Expansion and Double-Digit Revenue Growth in Both Life Sciences and Semiconductor Solutions CHELMSFORD, Mass., Nov. 10, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) today reported financial results... Read more
Introducing “Chemicals Informatics”: Software to Streamline New Product Research in the Chemical Industry
Tokyo, November 10, 2020 – Hitachi High-Tech Corporation today announced that Hitachi High-Tech Solutions Corporation (President: Masahiro Taniguchi / Hitachi High-Tech Solutions) is launching Chemicals Informatics – a new piece of software designed to help bring new high-value-added materials to market faster, as research and development (R&D) processes in the chemical sector has become more... Read more
Bringing Ultra-High Field MR Imaging from Research to Clinical: SIGNA 7.0T FDA Cleared
Waukesha, WI – November 10, 2020 – GE Healthcare today announced U.S. FDA 510(k) clearance of SIGNA 7.0T magnetic resonance imaging (MRI) scanner, the world’s most powerful FDA-cleared MRI device available. With a magnet approximately five times more powerful than most clinical systems, SIGNA 7.0T https://www.ge.com/news/press-releases/bringing-ultra-high-field-mr-imaging-from-research-to-clinical-signa-70t-fda-cleared Read more
PerkinElmer Brings ChemDraw Software to the Cloud, Enhancing Search and Collaboration Workflows
ChemOffice+ Cloud application enables chemists to quickly search chemical structures anddata while easily creating and sharing essential reports WALTHAM, Mass. – November 10, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched its newest ChemDraw® application, ChemOffice®+ Cloud, to simplify, facilitate and accelerate chemistry communication workflows. The ChemDraw... Read more
Thermo Scientific Axia ChemiSEM Increases Data Acquisition Speed, Simplicity for Materials Micro-Analysis
Thermo Scientific Axia ChemiSEM Increases Data Acquisition Speed, Simplicity for Materials Micro-Analysis New all-in-one SEM-EDS platform provides high-quality quantitative elemental data twice as fast as competing solutions HILLSBORO, Ore., Nov. 10, 2020 /PRNewswire/ — Thermo Fisher Scientific today unveiled the Thermo Scientific Axia ChemiSEM, a cost-effective, floor-model scanning electron microscope (SEM) that takes materials micro-structural analysis and... Read more
Consolidated Financial Statements for the Second Quarter Ended September 30, 2020 FY2021 (April 1, 2020 – September 30, 2020) [UNAUDITED]
Home Corporate Guide Message from the president Corporate Data Corporate History Corporate Executives Directions to Takara Bio Sustainability Initiatives Business Outline News Release Investor Relstions Management Policy Financial Data IR Library Stock Information IR Calendar IR News Disclosure Policy FAQ Contact IR User Guide Products Site About Us Business Outline News Release Investor Relstions Japanese... Read more